Updated:
Breakthrough 307
Breakthrough 307 is a private equity based in Casper; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
Breakthrough 307
Breakthrough 307 is an accredited angel investment group supporting entrepreneurs with startup capital and mentorship
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
Casper
Corporate office
Casper, WY, United States
Frequently asked questions
Who runs investment decisions at Breakthrough 307?
The firm does not disclose its leadership team publicly. No named principals appear on its website or in available business registries. This concentrated governance is typical of regional firms that rely on direct personal networks rather than institutional fundraising.
How does Breakthrough 307 source proprietary deal flow?
Given its sole office in Casper, the firm likely sources investments through deep ties within the Mountain West and broader US interior. Without a public deal roster or sector-specific marketing, its flow probably depends on founder referrals and legacy relationships rather than a broker-auction process.
Is Breakthrough 307 structured as a single family office or a traditional private equity firm?
Altss research categorizes it as an asset manager, not a single family office. The absence of disclosed wealth origins and the firm's stated strategy across multiple investment stages suggest it operates as an independent private equity manager, but a family-linked structure cannot be ruled out given the lack of public detail.
Does Breakthrough 307 participate in fund commitments or only direct deals?
The firm's strategy description points toward direct investments, covering seed, start-up, and growth stages. Without a disclosed fund-of-funds program or named co-investors, available information indicates it pursues a direct-deal model, possibly using special-purpose vehicles for individual transactions.
What investment stages does Breakthrough 307 typically target?
The firm targets a broad range, from early-stage seed rounds through growth equity. This full-lifecycle approach allows Breakthrough 307 to deploy capital as a company matures, though stage-specific check sizes or reserve strategies are not publicly detailed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: